Let’s put control
of osteoporosis
in patients’ hands
Osteoporosis can make people frail, but let’s remember these are individuals with unique tales to tell, who have lived full and productive lives.
Treatment with teriparatide has been shown to substantially improve patient quality of life (QoL) during treatment. The improved EQ-5D parameters include:1
- Mobility
- Self-care
- Usual activities
- Pain/discomfort
- Anxiety/depression
“Providing different devices for drug administration gives patients the opportunity to choose a device that addresses the challenges they face as an individual.” 2
EQ-5D, EuroQol 5-Dimensions questionnaire
References:
1. Ljunggren Ö, et al. BMC Musculoskelet Disord. 2013;14:251.
2. van den Bemt BJF, et al. Drug Deliv. 2019;26(1):384–392.
